Total Payments
$1,663
2024 Payments
$147.73
Companies
21
Transactions
77
Medicare Patients
4,873
Medicare Billing
$349,037
Payment Breakdown by Category
Food & Beverage$1,643 (98.8%)
Education$20.00 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,643 | 74 | 98.8% |
| Education | $20.00 | 3 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $813.51 | 22 | $0 (2024) |
| Amgen Inc. | $129.36 | 7 | $0 (2018) |
| Shire North American Group Inc | $73.36 | 4 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $70.33 | 5 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $69.52 | 5 | $0 (2018) |
| Novo Nordisk Inc | $63.54 | 4 | $0 (2018) |
| Allergan Inc. | $56.19 | 4 | $0 (2017) |
| PFIZER INC. | $55.75 | 3 | $0 (2018) |
| GlaxoSmithKline, LLC. | $52.99 | 4 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $41.43 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $147.73 | 2 | AstraZeneca Pharmaceuticals LP ($147.73) |
| 2023 | $24.29 | 1 | AbbVie Inc. ($24.29) |
| 2019 | $140.71 | 4 | AstraZeneca Pharmaceuticals LP ($140.71) |
| 2018 | $686.78 | 36 | AstraZeneca Pharmaceuticals LP ($246.89) |
| 2017 | $663.01 | 34 | AstraZeneca Pharmaceuticals LP ($278.18) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $128.54 | General |
| 05/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $9.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $117.56 | General |
| 03/01/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/15/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $6.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/17/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Central Nervous System (CNS) | ||||||
| 12/11/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/10/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Neuroscience | ||||||
| 12/04/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/27/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: DIABETES | ||||||
| 11/12/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Diabetes | ||||||
| 11/05/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Neuroscience | ||||||
| 10/16/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Respiratory | ||||||
| 10/01/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/11/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Diabetes | ||||||
| 08/28/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/06/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Endocrinology | ||||||
| 07/30/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $11.30 | General |
| Category: Cardiovascular | ||||||
| 07/23/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 07/09/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,253 | 1,588 | $223,428 | $83,492 |
| 2022 | 14 | 1,231 | 1,572 | $275,835 | $103,145 |
| 2021 | 15 | 1,125 | 1,377 | $232,478 | $85,472 |
| 2020 | 16 | 1,264 | 1,530 | $185,545 | $76,928 |
Total Patients
4,873
Total Services
6,067
Medicare Billing
$349,037
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 344 | 506 | $123,464 | $38,487 | 31.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 118 | 118 | $29,146 | $14,593 | 50.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 46 | 46 | $26,222 | $12,648 | 48.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 129 | 143 | $24,596 | $6,884 | 28.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 456 | 584 | $3,504 | $3,434 | 98.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 28 | 28 | $3,902 | $2,007 | 51.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $3,792 | $1,915 | 50.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 46 | 46 | $2,710 | $1,341 | 49.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,498 | $1,100 | 31.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 29 | $1,763 | $864.49 | 49.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 23 | $621.00 | $188.87 | 30.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 42 | $210.00 | $28.60 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 356 | 571 | $144,553 | $46,138 | 31.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 135 | 135 | $34,848 | $17,184 | 49.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 59 | 72 | $24,989 | $8,729 | 34.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 28 | 28 | $15,876 | $7,785 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 91 | 105 | $18,801 | $5,910 | 31.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 69 | 72 | $9,414 | $4,918 | 52.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 23 | 23 | $7,590 | $3,728 | 49.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 71 | 74 | $4,298 | $2,112 | 49.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 12 | 13 | $5,274 | $2,089 | 39.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 15 | 15 | $4,846 | $1,987 | 41.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 43 | 43 | $2,500 | $1,231 | 49.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 304 | 396 | $2,376 | $1,173 | 49.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 14 | $393.00 | $122.21 | 31.1% |
About Dr. Justin Wight, M.D
Dr. Justin Wight, M.D is a Family Medicine healthcare provider based in Cave Creek, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1467641811.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Justin Wight, M.D has received a total of $1,663 in payments from pharmaceutical and medical device companies, with $147.73 received in 2024. These payments were reported across 77 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,643).
As a Medicare-enrolled provider, Wight has provided services to 4,873 Medicare beneficiaries, totaling 6,067 services with total Medicare billing of $349,037. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Cave Creek, AZ
- Active Since 10/22/2007
- Last Updated 09/24/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1467641811
Products in Payments
- FARXIGA (Drug) $425.03
- BYDUREON (Drug) $100.50
- JARDIANCE (Drug) $70.33
- Trintellix (Drug) $64.59
- XARELTO (Drug) $58.82
- Prolia (Biological) $48.45
- MYDAYIS (Drug) $48.44
- Aimovig (Biological) $46.87
- ELIQUIS (Drug) $41.43
- VRAYLAR (Drug) $41.34
- JANUVIA (Drug) $35.59
- Repatha (Biological) $34.04
- Victoza (Drug) $32.22
- Ozempic (Drug) $31.32
- BEVESPI AEROSPHERE (Drug) $28.45
- XIFAXAN (Drug) $25.54
- LINZESS (Drug) $25.45
- VYVANSE (Drug) $24.92
- VIAGRA (Drug) $21.12
- TEKTURNA (Drug) $18.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cave Creek
Silvia Guerrero, M.d, M.D
Family Medicine — Payments: $964.05
Family Medicine $964.05
Dr. C. Daniel Murphy, M.d, M.D
Family Medicine — Payments: $123.76
Family Medicine $123.76
Scott Waters, Do, DO
Family Medicine — Payments: $98.83
Family Medicine $98.83
Dr. Mark Ballard, M.d, M.D
Family Medicine — Payments: $97.78
Family Medicine $97.78
Kim Miller, Md, MD
Family Medicine — Payments: $25.78
Family Medicine $25.78